Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)

Q: What does CUSIP 761330109 represent in this 13F holders report?

CUSIP 761330109 is the security identifier for RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q2 2018?

109 institutional investors reported RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q2 2018. Use the holders table for investor-level position and value details.

CUSIP: 761330109

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104,661,494
Total 13F shares: 34,870,390
Share change: +653,682
Total reported value: $957,229,930
Put/Call ratio: 102%
Price per share: $27.45
Number of holders: 109
Value change: +$13,863,223
Number of buys: 62
Number of sells: 50

Quarterly Holders Quick Answers

What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 761330109:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Essex Woodlands Management, Inc.	13F	Company	3.7%	3,842,047	$118,335,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.6%	3,814,034	$117,472,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	3.3%	3,437,417	$105,872,000	—	31 Mar 2018	13F
FRANKLIN RESOURCES INC	13F	Company	3%	3,173,162	$97,733,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	2.3%	2,410,444	$74,243,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	1.9%	2,013,231	$62,007,000	—	31 Mar 2018	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.7%	1,735,699	$53,460,000	—	31 Mar 2018	13F
NovaQuest Capital Management, L.L.C.	13F	Company	1.5%	1,558,426	$48,000,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.4%	1,494,441	$46,029,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	1.4%	1,483,037	$45,678,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	1.3%	1,322,517	$40,734,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.1%	1,139,111	$35,085,000	—	31 Mar 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.59%	618,957	$19,064,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.57%	592,910	$18,259,000	—	31 Mar 2018	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.56%	582,900	$17,953,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.32%	339,450	$10,455,000	—	31 Mar 2018	13F
Fosun International Ltd	13F	Company	0.31%	319,313	$9,835,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	262,392	$8,081,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	0.23%	245,636	$7,566,000	—	31 Mar 2018	13F
OppenheimerFunds, Inc.	13F	Company	0.22%	228,086	$7,025,000	—	31 Mar 2018	13F
Rhenman & Partners Asset Management AB	13F	Company	0.19%	203,181	$6,258,000	—	31 Mar 2018	13F
S.c.a. Candriam	13F	Individual	0.16%	171,000	$5,267,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.16%	170,401	$5,248,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.16%	167,729	$5,165,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	149,900	$4,617,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	134,616	$4,147,000	—	31 Mar 2018	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.12%	126,020	$3,881,000	—	31 Mar 2018	13F
Informed Momentum Co LLC	13F	Company	0.11%	113,096	$3,483,000	—	31 Mar 2018	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.11%	111,360	$3,430,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.08%	84,611	$2,606,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.08%	83,700	$2,578,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.08%	83,097	$2,559,000	—	31 Mar 2018	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.08%	79,959	$2,463,000	—	31 Mar 2018	13F
Allianz Asset Management GmbH	13F	Company	0.08%	79,437	$2,447,000	—	31 Mar 2018	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.07%	72,849	$2,244,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	67,235	$2,071,000	—	31 Mar 2018	13F
A.R.T. Advisors, LLC	13F	Company	0.06%	65,600	$2,020,000	—	31 Mar 2018	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.06%	63,900	$1,968,000	—	31 Mar 2018	13F
QS Investors, LLC	13F	Company	0.06%	63,156	$1,945,000	—	31 Mar 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.06%	62,545	$1,926,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	59,021	$1,818,000	—	31 Mar 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.06%	58,530	$1,802,000	—	31 Mar 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.05%	55,717	$1,717,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.05%	51,372	$1,582,000	—	31 Mar 2018	13F
Swiss National Bank	13F	Company	0.05%	51,050	$1,572,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	49,934	$1,538,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.05%	49,645	$1,529,000	—	31 Mar 2018	13F
ALPS ADVISORS INC	13F	Company	0.05%	47,981	$1,478,000	—	31 Mar 2018	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	47,855	$1,474,000	—	31 Mar 2018	13F
Global IMC LLC	13F	Company	0.04%	44,898	$1,383,000	—	31 Mar 2018	13F

Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2018

As of 30 Jun 2018, Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,870,390 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, Essex Woodlands Management, Inc., BlackRock Inc., FRANKLIN RESOURCES INC, Bank of New York Mellon Corp, ArrowMark Colorado Holdings LLC, NovaQuest Capital Management, L.L.C., VANGUARD GROUP INC, and Capital World Investors. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

118

Q2 2018 holders

109

Holder diff

-9

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.